Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Phillip Schneider and Paul Sekhri …